Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093468 · ClinicalTrials.gov registry record · Phase 2
Evaluation of MST-188 in Acute Lower Limb Ischemia
A Phase 2 study, sponsored by Mast Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02093468 is a Phase 2 study that was terminated before completion, run by Mast Therapeutics. The registered enrollment target is 4 participants.
The verdict
NCT02093468, a Phase 2 study, was terminated before completion, sponsored by Mast Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Interventions
- DRUG Saline
- DRUG MST-188
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093468
The ClinicalTrials.gov registry entry for NCT02093468 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mast Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02093468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02093468 about?
NCT02093468 is a clinical study titled "Evaluation of MST-188 in Acute Lower Limb Ischemia". The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected b...
What is the current status of trial NCT02093468?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2014-06.
What interventions are being tested in trial NCT02093468?
The interventions under investigation include: Saline (DRUG), MST-188 (DRUG).
Who is sponsoring clinical trial NCT02093468?
This trial is sponsored by Mast Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.